Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

FHS
July 31, 2023
2:48 pm

Researchers investigated the safety and pharmacokinetics of JNJ-54175446 in a double-blind, multicenter, randomized controlled trial (RCT).

Doctors fear workload, lawsuits with online medical records access: UK study

Most family doctors surveyed fear that giving patients online access to their medical records will increase their workload and the risks of litigation, suggest the

February 5, 2024

Opinion | An Evolutionary Perspective on Why the Lab Leak Theory Is Wrong

The House Select Subcommittee on the Coronavirus Pandemic published a “Hearing Wrap Up” in mid-July on the suppression of the lab leak hypothesis on COVID’s

August 16, 2023

Judge strikes down J&J talc unit’s second bankruptcy attempt over lack of ‘financial distress’

A New Jersey judge squashed a second bankruptcy attempt by Johnson & Johnson’s talc business Friday but did not preclude the company from making additional

August 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.